Global frequency, diagnosis, and treatment of hereditary angioedema with normal C1 inhibitor
Background: Hereditary angioedema (HAE) is a rare genetic disease, most frequently associated with deficiency or dysfunction in the C1 inhibitor protein. HAE with normal C1 inhibitor (HAE-nC1INH) lacks standardized diagnostic tests, limiting precise prevalence estimates and development of specific t...
Saved in:
Similar Items
-
Post-discontinuation Survival in Patients With Advanced NSCLC Receiving Immune Checkpoint Inhibitors: A Pooled Analysis of Prospective Cohort Studies
by: Yusuke Inoue, MD, PhD, et al.
Published: (2025-08-01) -
Independent association of a 17q21 variant with exacerbations in type 2–low adult asthma
by: Yumi Ishiyama, MD, et al.
Published: (2025-08-01) -
Intensity-Modulated Radiotherapy for Locally Advanced Lung Cancer in the Immunotherapy Era: A Prospective Study WJOG12019L
by: Hideyuki Harada, MD, PhD, et al.
Published: (2025-06-01) -
Patients’ Trajectory With Lung Cancer From Treatment Initiation to End-Of-Life: A Retrospective Cohort Study Using Claims Data in Japan
by: Yuri Ogura MD, et al.
Published: (2024-11-01) -
Deep Learning-Based Identification of Echocardiographic Abnormalities From Electrocardiograms
by: Goro Fujiki, MD, et al.
Published: (2025-01-01)